Skip to main content
HANGZHOU AGS MEDTECH CO.,LTD logo

HANGZHOU AGS MEDTECH CO.,LTD — Investor Relations & Filings

Ticker · 688581 ISIN · CNE100005ZF0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2023-04-26 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688581

About HANGZHOU AGS MEDTECH CO.,LTD

http://www.bioags.com/en/index.aspx

Hangzhou AGS MedTech Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical instruments, primarily focusing on endoscopic accessories. The product portfolio encompasses a comprehensive range of disposable devices for gastrointestinal and respiratory interventions, including biopsy forceps, hemoclips, injection needles, polypectomy snares, and guide wires. The company integrates advanced manufacturing processes with rigorous quality management systems, adhering to international standards such as ISO 13485, CE, and FDA. By providing high-precision diagnostic and therapeutic tools, the organization supports clinical procedures in gastroenterology and pulmonology. Its technical expertise facilitates the delivery of reliable solutions aimed at improving procedural outcomes and patient safety in global healthcare markets.

Recent filings

Filing Released Lang Actions
安杰思首次公开发行股票并在科创板上市招股意向书
Capital/Financing Update Classification · 95% confidence The document is titled as a 招股意向书, which translates to a 'Prospectus' or 'Offering Intention Document' for an initial public offering (IPO) on the Shanghai Stock Exchange's Science and Technology Innovation Board (科创板). It contains detailed information about the stock issuance, company background, risk factors, financial data, governance, and legal statements. This type of document is typically used to inform potential investors about the company's IPO and is not a regular financial report like an annual or interim report. It is also not a simple announcement or a regulatory filing but a comprehensive offering document. The closest fitting category in the provided filing definitions is 'Capital/Financing Update (CAP)', which covers updates on company fundraising and financing activities, including IPO prospectuses and related documents. Therefore, the document should be classified as a Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the full prospectus, not just an announcement or summary.
2023-04-26 Chinese
安杰思首次公开发行股票并在科创板上市发行安排及初步询价公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial public offering (IPO) of Hangzhou Anjiesi Medical Technology Co., Ltd. on the STAR Market (科创板) of the Shanghai Stock Exchange. It includes information about the issuance arrangement, preliminary inquiry, strategic placement, pricing, investor qualifications, subscription limits, lock-up periods, and timelines related to the IPO process. The document references regulatory approvals from the China Securities Regulatory Commission (CSRC) and compliance with various regulatory rules and guidelines for IPO issuance and underwriting. It also details the roles of the sponsor and underwriter, investor participation conditions, and legal and audit arrangements. This document is not a financial report, earnings release, or management discussion but rather an official announcement of the IPO issuance plan and preliminary inquiry process. Therefore, it fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPOs.
2023-04-26 Chinese
安杰思首次公开发行股票并在科创板上市招股意向书提示性公告
Regulatory Filings Classification · 95% confidence The document is titled as a "首次公开发行股票并在科创板上市招股意向书提示性公告" which translates to "Initial Public Offering and Listing on the STAR Market Prospectus Indicative Announcement." It contains detailed information about the IPO process, share issuance quantities, pricing methods, subscription codes, and important dates related to the offering. The document is an announcement related to the IPO prospectus and issuance arrangements rather than the full prospectus or financial report itself. It is a regulatory announcement informing investors about the IPO and related procedures. Given the nature of the document as an announcement of the IPO prospectus and issuance details, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-26 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.